HIGH-VOLUME · MALE-LED
testosterone Side Effects
testosterone (also sold as AndroGel, Testim) is HIGH-VOLUME in this FAERS book #159 of 524 by FAERS report count. Signature opener: MALE-LED - 10% of sex-coded reports are female (3,659 F / 34,487 M).
Data updated 2026-05-15
- 40,954
- FAERS reports
FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
testosterone reporting skew - 10% of sex-coded reports are female (3,659 F / 34,487 M). Volume band HIGH-VOLUME #159 of 524 by FAERS report count; caseload CASELOAD.
High-report extract for testosterone (AndroGel): 40,954 FAERS rows (2004-2025). Top named reactions: MYOCARDIAL INFARCTION, PAIN, DEEP VEIN THROMBOSIS. Outcome stamps DEATH-MARKED · HOSP-MID · MALE-LED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2004–2025). Stamps CASELOAD · DEATH-MARKED · HOSP-MID · MALE-LED.
MYOCARDIAL INFARCTION leads 3,269 of 40,954 reports
MALE-LED reporters · age peak 45-64
Male-led reporters (90% of sex-coded rows)
Age peak 45-64 (10,318 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 1,852 reports (4.5% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 617 |
| MYOCARDIAL INFARCTION | 366 |
| CARDIAC ARREST | 139 |
| PULMONARY EMBOLISM | 138 |
| PAIN | 127 |
| CEREBROVASCULAR ACCIDENT | 115 |
| INJURY | 80 |
| DEEP VEIN THROMBOSIS | 76 |
| ANXIETY | 75 |
| PNEUMONIA | 74 |
| ECONOMIC PROBLEM | 71 |
| EMOTIONAL DISTRESS | 62 |
| THROMBOSIS | 60 |
| COMPLETED SUICIDE | 58 |
| DRUG ABUSE | 55 |
| ACUTE MYOCARDIAL INFARCTION | 54 |
| CARDIO-RESPIRATORY ARREST | 54 |
| RENAL FAILURE | 54 |
| RESPIRATORY FAILURE | 53 |
| DYSPNOEA | 48 |
Reactions in Hospitalization Reports
Hospitalization mid-share (9,033, 22.1%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| MYOCARDIAL INFARCTION | 1,149 |
| PAIN | 1,011 |
| PULMONARY EMBOLISM | 1,002 |
| DEEP VEIN THROMBOSIS | 922 |
| CEREBROVASCULAR ACCIDENT | 899 |
| ANXIETY | 716 |
| ECONOMIC PROBLEM | 530 |
| ACUTE MYOCARDIAL INFARCTION | 495 |
| THROMBOSIS | 451 |
| INJURY | 414 |
| DYSPNOEA | 398 |
| PNEUMONIA | 397 |
| FATIGUE | 391 |
| CORONARY ARTERY DISEASE | 377 |
| ASTHENIA | 362 |
| EMOTIONAL DISTRESS | 342 |
| CHEST PAIN | 338 |
| CARDIAC FAILURE CONGESTIVE | 331 |
| FALL | 331 |
| ATRIAL FIBRILLATION | 322 |
How to read testosterone FAERS figures (CASELOAD · DEATH-MARKED · HOSP-MID)
FAERS holds 40,954 voluntary reports linked to testosterone (AndroGel, Testim), 2004-2025. Death is listed on 1,852 (4.5%). Hospitalization appears on 9,033 (22.1%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; MALE-LED is the page opener, not a per-patient risk.
Read with testosterone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 40,790 FAERS cases (Δ 164 lighter vs testosterone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · MALE-LED.
ABS(total_reports) peer at 41,632 FAERS cases (Δ 678 heavier vs testosterone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · MALE-LED.
ABS(total_reports) peer at 41,778 FAERS cases (Δ 824 heavier vs testosterone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · MALE-LED.
ABS(total_reports) peer at 39,831 FAERS cases (Δ 1,123 lighter vs testosterone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-MARKED · HOSP-MID · MALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 57.6 pp vs testosterone's DEATH-MARKED): CASELOAD · HOSP-MID.
testosterone sits in CASELOAD; high report volume tracks exposure and reporting culture more than per-patient risk. Methodology states the de-dup rules.